- Home
- COLL vs PSFE Comparison
COLL vs PSFE Comparison
Compare COLL & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- PSFE
- Stock Information
- Founded
- COLL 2002
- PSFE 1996
- Country
- COLL United States
- PSFE United Kingdom
- Employees
- COLL N/A
- PSFE N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- PSFE Business Services
- Sector
- COLL Health Care
- PSFE Consumer Discretionary
- Exchange
- COLL Nasdaq
- PSFE Nasdaq
- Market Cap
- COLL 958.8M
- PSFE 770.1M
- IPO Year
- COLL 2015
- PSFE N/A
- Fundamental
- Price
- COLL $36.04
- PSFE $13.86
- Analyst Decision
- COLL Strong Buy
- PSFE Sell
- Analyst Count
- COLL 4
- PSFE 4
- Target Price
- COLL $44.25
- PSFE $17.38
- AVG Volume (30 Days)
- COLL 463.5K
- PSFE 244.6K
- Earning Date
- COLL 11-06-2025
- PSFE 11-12-2025
- Dividend Yield
- COLL N/A
- PSFE N/A
- EPS Growth
- COLL N/A
- PSFE N/A
- EPS
- COLL 1.06
- PSFE N/A
- Revenue
- COLL $707,007,000.00
- PSFE $1,676,391,000.00
- Revenue This Year
- COLL $22.23
- PSFE $3.18
- Revenue Next Year
- COLL $2.78
- PSFE $7.05
- P/E Ratio
- COLL $34.38
- PSFE N/A
- Revenue Growth
- COLL 22.61
- PSFE 0.47
- 52 Week Low
- COLL $23.23
- PSFE $10.63
- 52 Week High
- COLL $42.29
- PSFE $26.25
- Technical
- Relative Strength Index (RSI)
- COLL 45.96
- PSFE 51.18
- Support Level
- COLL $34.71
- PSFE $13.77
- Resistance Level
- COLL $36.57
- PSFE $14.51
- Average True Range (ATR)
- COLL 1.25
- PSFE 0.51
- MACD
- COLL -0.59
- PSFE -0.05
- Stochastic Oscillator
- COLL 25.25
- PSFE 38.74
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.